Skip to main content
Gastroenterology Report logoLink to Gastroenterology Report
. 2019 Jan 8;7(3):205–211. doi: 10.1093/gastro/goy046

Management of complicated gallstones in the elderly: comparing surgical and non-surgical treatment options

Yousef Nassar 1,, Seth Richter 2
PMCID: PMC6573799  PMID: 31217985

Abstract

Objective

The aim of this study was to evaluate the differences in clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP), ERCP followed by cholecystectomy (EC) and percutaneous aspiration (PA) in the elderly population with choledocholithiasis.

Methods

We included a total of 43 338 elderly patients aged 60 years or older and 45 295 patients younger than 60 years for comparison in our study. Data were obtained from the Nationwide Inpatient Sample (Healthcare Utilization Project) for years 2001–14 by identifying patients who were admitted for gallstone complications based on the ICD 9 diagnostic code. Multiple logistic regression was used to calculate the odds of in-hospital mortality and to detect statistical differences among the treatment groups, age groups and between male and female patients. Univariate ordinary linear regression was used to compare the length of hospital stay and readmission frequency among the different age groups.

Results

The age of the patient affected mortality and the length of hospital stay after any type of procedure of gallstones removal. In a manner independent of the patient’s age, PA was associated with the highest risk of death and length of stay, while the EC was characterized by lowest mortality and ERCP by the shortest length of stay. Neither age of the patient nor the type of procedure affected the likelihood of readmission. The odds of death and the probability of readmission were not affected by patient sex. However, in patients aged between 60 and 79 years, the female gender predicted a shorter duration of stay in the hospital.

Conclusions

A patient’s age negatively affects the treatment outcomes of cholelithiasis with associated complications. The EC procedure appears to be the method of choice for the management of complicated gallstones in patients of all ages.

Keywords: Gallstone disease, elderly, cholecystectomy, endoscopic retrograde cholangiopancreatography, percutaneous aspiration

Introduction

Cholelithiasis or gallstone disease is characterized by high prevalence ranging from 7 to 15% [1–3]. The treatment and morbidity associated with this condition constitute a significant financial burden [4, 5]. In 2012, there were almost 400 000 admissions for cholelithiasis with cholecystitis in the USA alone, and the aggregate expenses for in-hospital treatment exceeded 4 billion dollars [4]. Almost 2000 deaths (0.5%) were reported among the patients suffering from gallstone disease [4]. Moreover, although the causal mechanism is unknown, the presence of cholelithiasis is associated with a 30% higher all-cause mortality, mostly due to cardiovascular events and cancer [3].

Between 5 and 30% of cholelithiasis patients have concurrent choledocholithiasis or gallstones lodged in the common bile duct (CBD) [6–8]. Endoscopic retrograde cholangiopancreatography (ERCP) is used for both diagnosis and treatment of choledocholithiasis [9–12]. It can be implemented prior to, during or after cholecystectomy and is considered to represent a low-risk intervention. Annually, 1.3 million procedures are performed and an overall complication rate is 5–10% [13, 14]. Patients undergoing either ERCP or cholecystectomy have a 70% lower risk of biliary disease recurrence within 1 year [15]. In another study, ERCP alone was shown to reduce the recurrence by 37% [16]. These data are consistent with the conclusion that ERCP only is not sufficient to reach an optimal treatment outcome and that ERCP should be combined with cholecystectomy for adequate stone clearance [17]. In comparison with ERCP alone, a smaller number of stones remain in the CBD after cholecystectomy [18]. However, cholecystectomy after ERCP appears not to be necessary for patients with acalculous cholecystitis [19].

With the increase in the age of the population [20], the number of elderly patients undergoing treatment for symptomatic gallstones is expected to increase [21]. In fact, the proportion of emergency and elective surgical cases involving older patients is on the rise [22]. Of relevance, elderly surgical patients are characterized by higher indices of comorbidities than younger subjects [23–25], posing an additional challenge in the management of gallbladder stones. Although the mortality rate after cholecystectomy remains low (0.2–0.3%) [26–28], this fraction is increased in the older population and with increasing comorbidities. In fact, elderly patients were 7–10 times more likely to die post-operatively [26, 29]. Additionally, approximately 1% of patients who undergo laparoscopic cholecystectomy suffer from a procedure-related CBD injury. This adverse event is more common in the elderly and results more often in death in this age group [30]. Patients affected by diseases of the heart, lungs and kidneys, as well as type 2 diabetes—conditions more frequent in the older population—are more likely to die following cholecystectomy [27, 29, 31].

In order to lessen the risk of morbidity and mortality associated with cholecystectomy, elderly patients are recommended to undergo laparoscopic instead of open cholecystectomy [32]. Elective surgeries are preferred over emergency surgery, as they have a lower perioperative risk [33]. ERCP was found to be safe and effective for the elderly [10, 12, 34, 35]. However, combining this method with laparoscopic cholecystectomy, while improving the removal of gallbladder stones, may lead to increased complications such as bile leaks or adhesions [36, 37]. Alternatively, the reason for these complications might not be the ERCP itself, but pre-existing pathologies that prompted the use of ERCP in the first place [38]. Regardless of the underlying cause-and-effect relationships, the use of ERCP positively correlates with the necessity for conversion from laparoscopic to open surgery [39–42].

To date, only one study compared the outcomes of patients who underwent ERCP with and without cholecystectomy among the elderly and concluded that cholecystectomy after the ERCP does not provide a benefit to patients older than 80 years [43]. In view of the limited information regarding the impact of various types of treatment of gallbladder disease in the oldest patients, we have designed a study aiming at the comparison of in-hospital mortality, length of hospital stay and readmission rates after ERCP alone and ERCP followed by laparoscopic cholecystectomy in patients 60 years of age or older. Patients undergoing percutaneous aspiration (PA) were also included in the comparisons, since this protocol is considered to be a third-line option for the management of complicated gallstone disease in surgically high-risk patients [44]. Since the female gender was postulated to have a protective role against the complications of gallstone treatment [15, 16], the differences by gender were analysed as well.

Methods

Study design

This retrospective cohort study was performed using the Healthcare Cost and Utilization Project–Nationwide Inpatient Sample (HCUP-NIS) data from the years 2001–14. The HCUP-NIS is a national database of patients admitted to hospitals across the USA. The study included patients 60 years of age or older who were assigned the ICD 9 diagnostic codes of cholelithiasis with associated complications such as choledocholithiasis (574.xx). Three treatment groups were analysed: patients who underwent ERCP with cholecystectomy, patients who underwent ERCP only and patients who were treated with PA only. Subjects with incomplete data and those who had complications of gallbladder perforation were excluded from the analysis. Patients with open cholecystectomy were excluded. A total of 43 338 patients satisfied the inclusion and exclusion criteria of the study; 20 462 patients underwent ERCP with laparoscopic cholecystectomy (the EC group), 21 938 patients underwent ERCP alone (the ERCP group) and 938 patients underwent percutaneous aspiration (the PA group). For comparison with the younger population, data of 45 295 patients younger than 60 years was included (mean age: 40.49 ± 13.02 years) for comparison.

Statistical analysis

Statistical analysis was performed with the SAS statistical package, version 9.4. Multiple logistic regression was used to calculate the odds of in-hospital mortality and to detect statistical differences among the treatment groups (EC, ERCP and PA), among the age groups (less than 60 years, 60–69 years, 70–79 years and 80 years or older) and between male and female patients. Univariate ordinary linear regression was used to compare the length of hospital stay and readmission frequency among the groups. In all analyses, the results were corrected for confounding variables, such as the age at admission, gender and comorbidities; a full list of performed adjustments is included under each table. Data are presented as a mean ± standard deviation. A P-value ≤0.05 was considered statistically significant.

Results

Patients

The average age of the elderly patients included in the study was 75.6 ± 8.7 years. Small but statistically significant differences in age were present among the treatment groups, with the EC patients being the youngest and the PA patients being the oldest. Males constituted a majority of EC and ERCP patients, while both genders were equally represented in the PA group. In each treatment group, the patients were predominantly Caucasian, and the proportion of Caucasian patients did not differ among the groups. Approximately half of the EC procedures were performed in a fully equipped operating room, while a significantly higher fraction, more than 90%, of ERCP and PA treatments took place outside operating rooms. Patients undergoing ERCP and PA were more likely to be affected by a chronic disease than those subjected to EC (Table 1). The incidence of ischemic heart disease, heart failure, chronic obstructive pulmonary disease and cancer was, respectively, 71, 178, 32 and 116% higher in PA than in the EC patients. All differences among the treatment groups were accounted for in subsequent analyses that were corrected for confounding variables.

Table 1.

Patient characteristics

EC (N = 20 462) ERCP (N = 21 938) PA (N = 938)
Age (years, mean ± SD) 74.4 ± 8.3 76.7 ± 8.9a 77.4 ± 9.1a,b
Gender, n (%)
  Male 8925 (44.9) 9327 (42.5)a 471 (50.2)a,b
  Female 11 537 (55.1) 12 611 (57.5)a 467 (49.8)a,b
Ethnicity
  White 13 131 (75.7) 13 902 (63.3) 599 (63.9)
  Black 968 (5.6) 1024 (5.6) 79 (9.5)
  Hispanic 2135 (12.3) 2012 (11.0) 97 (11.7)
  Asian or Pacific Islander 589 (3.4) 844 (4.6) 21 (2.5)
  Native American 67 (0.4) 82 (0.5) 3 (0.4)
  Other or unknown 461 (2.7) 487 (2.7) 29 (3.5)
Procedure in a major operating room
  Yes 10 613 (51.9) 640 (2.9)a 94 (10.0)a,b
  No or unknown 9849 (48.1) 21 298 (97.1)a 844 (90.0)a,b
Chronic disease
 Ischemic heart disease 4982 (24.4) 6058 (27.6)a 387 (41.3)a,b
 Heart failure 2283 (11.2) 3221 (14.7)a 302 (32.2)a,b
  Chronic obstructive pulmonary disease 3231 (15.8) 3603 (16.4) 195 (20.8)a,b
  Cancer 757 (3.7) 1582 (7.2)a 87 (9.3)a,b
  Any of the above 8499 (41.5) 10 496 (47.8)a 628 (7.0)a,b

ERCP, endoscopic retrograde cholangiopancreatography; EC, ERCP followed by cholecystectomy; PA, percutaneous aspiration.

a,b

Indicate a statistically significant difference vs EC and ERCP groups, respectively.

In-hospital mortality

In comparison with the younger group, less than 60 years of age, the rate of death following removal of gallbladder stones was significantly increased in patients aged 60 years or older (Table 2 and Supplementary Table 1). Specifically, the unadjusted in-hospital mortality in the age group greater than 60 years of age compared to those less than 60 years old was 12.1-fold (1.21 vs 0.1%), 4.3-fold (2.09 vs 0.49%) and 1.7-fold (18.87 vs 11.14%) higher in patients undergoing EC, ERCP and PA, respectively. In all age groups, ERCP carried higher odds of death than EC and PA was associated with higher odds of death than EC and ERCP (Table 2).

Table 2.

In-hospital mortality

Age, years Treatment No. of patients Deaths, n (%) Odds ratio (95% CI)a P-value
<60 EC 27 597 27 (0.10) Reference
ERCP 17 357 85 (0.49) 6.37 (3.77, 10.76) <0.001
PA 341 38 (11.14) 111.25 (60.51, 204.52) <0.001
≥60 EC 20 462 156 (1.21) Reference
ERCP 21 938 459 (2.09) 3.07 (2.46, 3.85) <0.001
PA 938 177 (18.87) 29.97 (22.95, 39.15) <0.001
60–69 EC 7453 19 (0.25) Reference
ERCP 6279 100 (1.59) 7.30 (4.17, 12.77) <0.001
PA 244 52 (21.31) 100.89 (54.70, 186.07) <0.001
70–79 EC 7596 58 (0.76) Reference
ERCP 7541 154 (2.04) 2.95 (2.04, 4.28) <0.001
PA 313 52 (16.61) 25.74 (16.22, 40.85) <0.001
≥80 EC 5413 79 (1.46) Reference
ERCP 8118 205 (2.53) 2.03 (1.46, 2.83) <0.001
PA 381 73 (19.16) 17.24 (11.47, 25.90) <0.001

ERCP, endoscopic retrograde cholangiopancreatography; EC, ERCP followed by cholecystectomy; PA, percutaneous aspiration; CI, confidence interval.

a

Adjusted for age, gender, ethnicity (white/others), major operating room procedure (yes/no), ischemic heart disease, heart failure, chronic obstructive pulmonary disease and cancer.

Among the older cohort of patients, stratified by 10-year age intervals, the effect of age on the rate of death was dependent on the type of procedure performed. In comparison with patients 60–69 years old, the odds of in-hospital death after EC were 2.65-fold higher in the 70- to 79-year-old group and 4.82-fold higher in patients 80 years of age or older. However, in patients undergoing ERCP, the age had a much smaller impact on the rate of death; corresponding values were, respectively, 1.16-fold and 1.36-fold, and only the latter change was statistically significant. Moreover, there was no difference in the rate of death following the PA treatment among the three age groups. In comparison between the groups of 70- to 79-year-old patients and those aged 80 years or older, higher mortality was noted only in the EC group, but not in the ERCP and PA groups (Supplementary Table 2). When comparing patients by 10 year age intervals, patients aged 60–69 years of age undergoing ERCP only had an increased in-hospital mortality rate 7.30 times higher than those undergoing EC. Patients undergoing PA in this age group had a 100.89 times higher risk of in-hospital mortality compared to those undergoing EC. In patients aged 70–79, ERCP only was associated with a 2.95-fold higher in-hospital mortality than those undergoing EC. PA in this age group was associated with a 25.74-fold higher risk of in-hospital death when compared to EC. In the 80+ age group of patients, those who underwent ERCP only had a higher mortality rate of 2.03-fold higher mortality rate than the EC group. Patients in this age group undergoing PA had a 17.24-fold higher in-hospital death rate than those undergoing EC (Table 2).

A patient’s gender did not affect the rate of death after EC, ERCP or PA, regardless whether all patients 60 years or older were considered together or were stratified according to their age using the 10-year intervals. The overall pattern of the impact of the type of procedure on the risk of death, with PA being associated with the highest odds, followed by ERCP and EC, was not changed when the analysis was performed separately for male and female patients (Supplementary Table 3).

Post-operative hospital length of stay

The length of stay in the hospital after the treatment differed between patients aged 60 years or older and the younger group (Table 3 and Supplementary Table 4). The unadjusted length of stay was 22% (7.8 vs 6.1 days) and 11% (7.2 vs 6.5 days) longer in older patients undergoing EC and ERCP, respectively. In contrast, older patients subjected to PA were characterized by 16% shorter hospital stay (15.5 vs 18.4 days) than the younger group treated by the same protocol. In patients 60 years or older, ERCP was associated with shorter length of stay than EC and PA in all age groups including 60–69, 70–79 and 80+ age groups; the latter procedure was characterized by almost two-fold longer hospital stay than EC and ERCP (Table 3).

Table 3.

Post-operative hospital length of stay (LOS)

Age, years Treatment No. of patients LOS, days Odds ratio (95% CI)a P-value
<60 EC 27 597 6.1 ± 4.9 Reference
ERCP 17 357 6.5 ± 8.1 6.37 (3.77, 10.76) <0.001
PA 341 18.4 ± 19.6 12.16 (11.45, 12.87) <0.001
≥60 EC 20 462 7.8 ± 5.9 Reference
ERCP 21 938 7.2 ± 7.5 0.13 (–0.05, 0.31) 0.16
PA 938 15.5 ± 14.4 8.06 (7.59, 8.54) <0.001
60–69 EC 7453 7.1 ± 5.6 Reference
ERCP 6279 7.0 ± 8.4 1.06 (0.72, 1.39) <0.001
PA 244 17.7 ± 16.4 10.99 (10.04, 11.94) <0.001
70–79 EC 7596 7.8 ± 6.0 Reference
ERCP 7541 7.2 ± 7.2 0.22 (–0.06, 0.51) 0.13
PA 313 16.7 ± 15.6 9.42 (8.62, 10.22) <0.001
≥80 EC 5413 8.7 ± 6.0 Reference
ERCP 8118 7.2 ± 7.3 –1.03 (–1.35, –0.71) <0.001
PA 381 13.4 ± 11.9 4.58 (3.84, 5.32) <0.001

ERCP, endoscopic retrograde cholangiopancreatography; EC, ERCP followed by cholecystectomy; PA, percutaneous aspiration.

a

Adjusted for age, gender, ethnicity (white/others), major operating room procedure (yes/no), ischemic heart disease, heart failure, chronic obstructive pulmonary disease and cancer.

Among the patients undergoing the EC treatment, those aged 80 years or more had the longest duration of stay in the hospital after surgery, followed by the 70- to 79-year-old and 60- to 69-year-old patients. The differences between these three age groups were statistically significant. In contrast, the length of stay after ERCP was not dependent on age. Patients undergoing PA who were aged 80 years or older were staying in the hospital for approximately 3 days (∼25%) shorter period than patients aged 60–69 and 70–79 years (Supplementary Table 5).

When analysis in the combined group of older patients was performed separately for men and women, the length of stay continued to be shortest after ERCP and longest after PA in both sexes. Of relevance, females 60 years or older had a shorter hospital stay following any type of treatment than men. However, when the patients were stratified according to their age using the 10-year intervals, the gender difference was present only in patients 60–69 years old, but not in patients aged 70–79 and more than 80 years (Supplementary Table 6).

Readmission related to gallbladder disease

For this analysis, data of patients admitted in 2010 and followed up until 2014 were utilized. There were no statistically significant differences in the rates of hospital readmission due to complications of gallbladder disease among those patients who underwent ERCP, those who underwent ERCP with cholecystectomy and those who were subjected to PA in any of the age groups studied (Table 4 and Supplementary Table 7). In addition, neither age nor gender had an effect on the fraction of patients that had to be readmitted (Supplementary Tables 8 and 9).

Table 4.

Hospital readmission after the treatment

Age, years Treatment No. of patients No. of revisits Revisiting patients, n (%) Change, % (95% CI)a P-value
<60 EC 4203 341 286 (6.80) Reference
ERCP 2527 173 153 (6.05) –18.3 (–45.2, 21.8) 0.32
PA 53 6 6 (11.32) 42.4 (–29.4, 187.6) 0.32
≥60 EC 3196 251 217 (6.79) Reference
ERCP 3364 275 232 (6.90) 19.0 (–13.9, 64.5) 0.29
PA 153 12 10 (6.54) 15.6 (–28.1, 85.9) 0.55
60–69 EC 1189 85 74 (6.22) Reference
ERCP 1020 82 65 (6.37) 3.4 (–39.2, 75.7) 0.90
PA 41 6 5 (12.20) 74.4 (–25.1, 306.2) 0.20
70–79 EC 1164 99 87 (7.47) Reference
ERCP 1061 87 75 (7.07) 31.6 (–24.4, 129.0) 0.33
PA 43 1 1 (2.33) –14.8 (–64.7, 105.6) 0.72
≥80 EC 843 67 56 (6.64) Reference
ERCP 1283 106 92 (7.17) 16.7 (–36.5, 114.4) 0.62
PA 69 5 4 (5.80) 6.9 (–51.4, 135.3) 0.87

ERCP, endoscopic retrograde cholangiopancreatography; EC, ERCP followed by cholecystectomy; PA, percutaneous aspiration.

a

Adjusted for age, gender, ethnicity (white/others), major operating room procedure (yes/no), initial admission month (January through December), ischemic heart disease, heart failure, chronic obstructive pulmonary disease and cancer at the time of initial admission.

Discussion

The results of the present study indicate that the age of the patient is a significant factor determining the likelihood of death and the length of hospital stay after any type of procedure of gallstones removal. In a manner independent of the patient’s age, PA is associated with the highest risk of death and length of stay, while the EC with the lowest mortality and ERCP with the shortest length of stay. Neither age of the patient nor the type of procedure affects the likelihood of necessity for hospital readmission for issues related to gallbladder disease. A patient’s sex does not affect the odds of death after the treatment and the probability of being readmitted to the hospital. However, in patients aged between 60 and 79 years, the female gender predicts a shorter duration of stay in the hospital.

Additional relevant information was obtained when sub-analysis by age group was performed. Although mortality was found to be significantly higher in ERCP compared to EC in patients 60–79 years old, death rates were found to be comparable between these two protocols in patients more than 80 years old. Therefore, ERCP with cholecystectomy was found to be more beneficial than ERCP alone for patients of all age groups. Of note, a similar conclusion was reached in a study by Yasui et al. [43], who found a comparable rate of complications and recurrence of stones between patients who did and did not undergo cholecystectomy.

Several other studies provide information relevant to the interpretation of the current results. The rate of conversion to open surgery was shown to be highest in the population of octogenarians [45], which may be an additional factor contributing to higher mortality and longest in-hospital stay reported here for the oldest group of subjects. In another study, data obtained in patients aged more than 65 years indicated that the relapse of gallstone-related disease was two times more frequent in ERCP patients than in those undergoing cholecystectomy [46]. A much smaller, 16.8%, difference was seen in our analysis, and it did not reach statistical significance; the reason for this discrepancy remains to be established. In agreement with our results, a study including 152 patients did not find differences in the rate of complications following cholecystectomy between a group of older (average age 78 years) and younger (average age 68 years) patients [47]. Finally, it has been reported that age over 65 years is strongly associated with a higher probability of bile duct injury [48]; this might have been an additional factor contributing to longer in-hospital stay of older patients documented in the current study.

A shorter hospital stay was observed in patients after ERCP compared to EC. This contradicts the findings of a meta-analysis of eight trials that showed comparable results between ERCP and EC [18]. Previous studies also reported that the number of retained stones is lower when surgical treatment is done [17, 18]. However, the present work does not support this notion, since readmission rates were found to be comparable between ERCP and EC. The readmission rate was only 7% even if the stones were removed via ERCP. It must be noted, however, that this rate is considerably lower in comparison with a study by Bergman et al. [15], in which a third of the patients experienced a recurrence of the disease within 2 months.

The accumulated data indicate that the management of cholelithiasis with associated complications poses a challenge in elderly patients. The clinical relevance of the finding of the current analysis is further broadened by the fact that the prevalence of gallstone disease increases with age [21, 49] and the human population is aging; the number of people aged 65 years or more is predicted to double by 2050 [20]. A combination of these two trends can be expected to result in a dramatic increase in the incidence of gallbladder disease in the near future. Therefore, the paucity of data on the clinical outcomes of different types of treatment is disconcerting. The only published study involving a large number of patients from multiple healthcare establishments provided valuable information regarding the impact of the age of patients on clinical outcomes but failed to analyse the contribution of the type of procedure employed [49]. Also, the important question of whether the patient’s gender affects the outcome was not addressed.

The available data on gender differences in the outcomes of the treatment of gallbladder disease are conflicting. A study utilizing the large HCUP-NIS database documented that women admitted with cholecystitis had lower in-hospital mortality than men and shorter length of in-hospital stay [50]. However, the women included in that study were younger and had fewer comorbidities than men, and the racial composition was different in the two sex groups. These variables might have influenced the gender difference in mortality, which was not detected in our study. In agreement with the present work, the length of post-operative hospital stay was shown to be longer in men when patients undergoing laparoscopic cholecystectomy were analysed [47]. Another study, also focused on laparoscopic cholecystectomy, failed to identify gender differences in clinical outcomes of the procedure [51]. In contrast, in a North Korean population, complications of the laparoscopic protocol, such as hydrops, empyema, pericholecystic abscess and gangrene, were more frequent in males [52]. It is unclear whether this difference is related to the ethnicity of the patients or reflects the specific types of complications that were taken into account. In this regard, male gender was shown to be associated with a higher incidence of local post-operative complications of laparoscopic cholecystectomy, but not with systemic complications [33]. It should be emphasized that the present study has the advantage of analysing the gender difference in the context of age and the type of procedure performed. Such a comprehensive approach to the question of gender differences in the outcomes of gallbladder disease treatment was never before applied.

Limitations of the current study have to be acknowledged. The specific type of complications associated with cholelithiasis was not taken into account. By design, the study did not include outpatient cholecystectomy procedures, which are likely to include less complicated cases [40]. It must also be noted that, because of the large size of the patient population, not all statistically significant findings must be inevitably clinically meaningful. Lastly, the skills of the medical personnel could affect patient outcomes. However, the large number of facilities that generated the data deposited in the HCUP-NIS database minimizes the impact of this potential variability. The nature of this database prevents yielding specific information about the procedures involved and other comorbidities that may have contributed to mortality of the patients included in the study. This creates inherent bias that is unfortunately unavoidable due to the nature of the database.

Funding

No source of funding was provided for this study.

Conflict of interest

None declared.

Supplementary Material

goy046_Supplementary_Data

References

  • 1. Shabanzadeh DM, Sørensen LT, Jørgensen T.. Gallstone disease and mortality: a cohort study. Int J Public Health 2017;62:353–60. [DOI] [PubMed] [Google Scholar]
  • 2. Stinton LM, Shaffer EA.. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver 2012;6:172–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Ruhl CE, Everhart JE.. Gallstone disease is associated with increased mortality in the United States. Gastroenterology 2011;140:508–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Peery AF, Crockett SD, Barritt AS. et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology 2015;149:1731–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol 2018;34:81–9. [DOI] [PubMed] [Google Scholar]
  • 6. Mishra T, Lakshmi KK, Peddi KK.. Prevalence of cholelithiasis and choledocholithiasis in morbidly obese South Indian patients and the further development of biliary calculus disease after sleeve gastrectomy, gastric bypass and mini gastric bypass. Obes Surg 2016;26:2411–7. [DOI] [PubMed] [Google Scholar]
  • 7. Rahal MA, Rammal MO, Karaoui W. et al. Predictors of bile tree pathology in patients presenting with gallbladder disease. Eur J Gastroenterol Hepatol 2017;29:1017–21. [DOI] [PubMed] [Google Scholar]
  • 8. Paci P, Mayo NE, Kaneva PA. et al. Determinants of variability in management of acute calculous cholecystitis. Surg Endosc 2018;32:1858–66. [DOI] [PubMed] [Google Scholar]
  • 9. Hu KC, Chu CH, Wang HY. et al. How does aging affect presentation and management of biliary stones? J Am Geriatr Soc 2016;64:2330–5. [DOI] [PubMed] [Google Scholar]
  • 10. Ukkonen M, Siiki A, Antila A. et al. Safety and efficacy of acute endoscopic retrograde cholangiopancreatography in the elderly. Dig Dis Sci 2016;61:3302–8. [DOI] [PubMed] [Google Scholar]
  • 11. Molvar C, Glaenzer B.. Choledocholithiasis: evaluation, treatment, and outcomes. Semin Intervent Radiol 2016;33:268–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Zippi M, De Felici I, Pica R. et al. Comparison of endoscopic retrograde cholangiopancreatography between elderly and younger patients for common bile duct stones. Clin Ter 2013;164:e353–8. [DOI] [PubMed] [Google Scholar]
  • 13. Rustagi T, Jamidar PA.. Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events. Gastrointest Endosc Clin N Am 2015;25:107–21. [DOI] [PubMed] [Google Scholar]
  • 14. Loor MM, Morancy JD, Glover JK. et al. Single-setting endoscopic retrograde cholangiopancreatography (ERCP) and cholecystectomy improve the rate of surgical site infection. Surg Endosc 2017;31:5135–42. [DOI] [PubMed] [Google Scholar]
  • 15. Bergman S, Al-Bader M, Sourial N. et al. Recurrence of biliary disease following non-operative management in elderly patients. Surg Endosc 2015;29:3485–90. [DOI] [PubMed] [Google Scholar]
  • 16. Trust MD, Sheffield KM, Boyd CA. et al. Gallstone pancreatitis in older patients: are we operating enough? Surgery 2011;150:515–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Huang RJ, Barakat MT, Girotra M. et al. Practice patterns for cholecystectomy after endoscopic retrograde cholangiopancreatography for patients with choledocholithiasis. Gastroenterology 2017;153:762–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Dasari BV, Tan CJ, Gurusamy KS. et al. Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev 2013;CD003327. [DOI] [PubMed] [Google Scholar]
  • 19. Kageoka M, Watanabe F, Maruyama Y. et al. Long-term prognosis of patients after endoscopic sphincterotomy for choledocholithiasis. Dig Endosc 2009;21:170–5. [DOI] [PubMed] [Google Scholar]
  • 20. He W, Goodkind D, Kowal P, U.S. Census Bureau. An Aging World: 2015. International Population Reports, P95/16–1, U.S. Washington, DC: Government Publishing Office, 2016. [Google Scholar]
  • 21. Agrusa A, Romano G, Frazzetta G. et al. Role and outcomes of laparoscopic cholecystectomy in the elderly. Int J Surg 2014;12(Suppl 2): S37–9. [DOI] [PubMed] [Google Scholar]
  • 22. Etzioni DA, Liu JH, O’Connell JB. et al. Elderly patients in surgical workloads: a population-based analysis. Am Surg 2003;69:961–5. [PubMed] [Google Scholar]
  • 23. Laor A, Tal S, Guller V. et al. The Charlson Comorbidity Index (CCI) as a mortality predictor after surgery in elderly patients. Am Surg 2016;82:22–7. [PubMed] [Google Scholar]
  • 24. Piccirillo JF, Vlahiotis A, Barrett LB. et al. The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 2008;67:124–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Turrentine FE, Wang H, Simpson VB. et al. Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg 2006;203:865–77. [DOI] [PubMed] [Google Scholar]
  • 26. Sandblom G, Videhult P, Crona Guterstam Y. et al. Mortality after a cholecystectomy: a population-based study. HPB (Oxford) 2015;17:239–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Scollay JM, Mullen R, McPhillips G. et al. Mortality associated with the treatment of gallstone disease: a 10-year contemporary national experience. World J Surg 2011;35:643–7. [DOI] [PubMed] [Google Scholar]
  • 28. Pålsson S, Saliba G, Sandblom G.. Outcome after cholecystectomy in the elderly: a population-based register study. Scand J Gastroenterol 2016;51:974–8. [DOI] [PubMed] [Google Scholar]
  • 29. Nimptsch U, Mansky T.. Deaths following cholecystectomy and herniotomy. Dtsch Arztebl Int 2015;112:535–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Halbert C, Altieri MS, Yang J. et al. Long-term outcomes of patients with common bile duct injury following laparoscopic cholecystectomy. Surg Endosc 2016;30:4294–9. [DOI] [PubMed] [Google Scholar]
  • 31. Kiu KT, Chen HL, Huang MT. et al. Outcome analysis of patients with gallstone disease receiving cholecystectomy: a population-based cohort study. Digestion 2017;95:132–9. [DOI] [PubMed] [Google Scholar]
  • 32. Caglia P, Costa S, Tracia A. et al. Can laparoscopic cholecystectomy be safety performed in the elderly? Ann Ital Chir 2012;83:21–4. [PubMed] [Google Scholar]
  • 33. Giger UF, Michel JM, Opitz I. et al. Risk factors for perioperative complications in patients undergoing laparoscopic cholecystectomy: analysis of 22, 953 consecutive cases from the Swiss Association of Laparoscopic and Thoracoscopic Surgery database. J Am Coll Surg 2006;203:723–8. [DOI] [PubMed] [Google Scholar]
  • 34. Kakucs T, Harsányi L, Kupcsulik P. et al. The role of laparoscopy in cholecystectomy in patients 80 years old and older [in Hungarian]. Orv Hetil 2016;157:185–90. [DOI] [PubMed] [Google Scholar]
  • 35. Lu Y, Chen L, Jin Z. et al. Is ERCP both effective and safe for common bile duct stones removal in octogenarians? A comparative study. Aging Clin Exp Res 2016;28:647–52. [DOI] [PubMed] [Google Scholar]
  • 36. Allen NL, Leeth RR, Finan KR. et al. Outcomes of cholecystectomy after endoscopic sphincterotomy for choledocholithiasis. J Gastrointest Surg 2006;10:292–6. [DOI] [PubMed] [Google Scholar]
  • 37. Sarıtaş Ü, Üstündağ Y, Baron TH.. Prevention of post-ERCP pancreatitis. Turk J Gastroenterol 2011;22:449–63. [DOI] [PubMed] [Google Scholar]
  • 38. Çakır M, Küçükkartallar T, Tekin A. et al. Does endoscopic retrograde cholangiopancreatography have a negative effect on laparoscopic cholecystectomy? Ulus Cerrahi Derg 2015;31:128–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Cinar H, Ozbalci GS, Tarim IA. et al. Factors affecting the conversion to open surgery during laparoscopic cholecystectomy in patients with cholelithiasis undergoing ERCP due to choledocholithiasis. Ann Ital Chir 2017;88:229–36. [PubMed] [Google Scholar]
  • 40. Nielsen LB, Harboe KM, Bardram L.. Cholecystectomy for the elderly: no hesitation for otherwise healthy patients. Surg Endosc 2014;28:171–7. [DOI] [PubMed] [Google Scholar]
  • 41. Qasaimeh GR, Banihani MN.. Laparoscopic cholecystectomy in the elderly and young: a comparative study. Hepatogastroenterology 2012;59:22–5. [DOI] [PubMed] [Google Scholar]
  • 42. Ahn KS, Kim YH, Kang KJ. et al. Impact of preoperative ERCP on laparoscopic cholecystectomy: a case-controlled study with propensity score matching. World J Surg 2015;39:2235–42. [DOI] [PubMed] [Google Scholar]
  • 43. Yasui T, Takahata S, Kono H. et al. Is cholecystectomy necessary after endoscopic treatment of bile duct stones in patients older than 80 years of age? J Gastroenterol 2012;47:65–70. [DOI] [PubMed] [Google Scholar]
  • 44. Katabathina VS, Zafar AM, Suri R.. Clinical presentation, imaging, and management of acute cholecystitis. Tech Vasc Interv Radiol 2015;18:256–65. [DOI] [PubMed] [Google Scholar]
  • 45. Lee W. Cholecystectomy in octogenarians: recent 5 years’ experience. Korean J Hepatobiliary Pancreat Surg 2013;17:162–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. García-Alonso FJ, de Lucas Gallego M, Bonillo Cambrodón D. et al. Gallstone-related disease in the elderly: is there room for improvement? Dig Dis Sci 2015;60:1770–7. [DOI] [PubMed] [Google Scholar]
  • 47. Ambe PC, Weber SA, Christ H. et al. Primary cholecystectomy is feasible in elderly patients with acute cholecystitis. Aging Clin Exp Res 2015;27:921–6. [DOI] [PubMed] [Google Scholar]
  • 48. Aziz H, Pandit V, Joseph B. et al. Age and obesity are independent predictors of bile duct injuries in patients undergoing laparoscopic cholecystectomy. World J Surg 2015;39:1804. 8 [DOI] [PubMed] [Google Scholar]
  • 49. Kuy S, Sosa JA, Roman SA. et al. Age matters: a study of clinical and economic outcomes following cholecystectomy in elderly Americans. Am J Surg 2011;201:789–96. [DOI] [PubMed] [Google Scholar]
  • 50. Dua A, Dua A, Desai SS. et al. Gender based differences in management and outcomes of cholecystitis. Am J Surg 2013;206:641–6. [DOI] [PubMed] [Google Scholar]
  • 51. Bazoua G, Tilston MP.. Male gender impact on the outcome of laparoscopic cholecystectomy. JSLS 2014;18:50–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Lee HK, Han HS, Min SK. et al. Sex-based analysis of the outcome of laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 2005;92:463–6. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

goy046_Supplementary_Data

Articles from Gastroenterology Report are provided here courtesy of Oxford University Press

RESOURCES